UnitedHealth Group IncorporatedUnitedHealth announces $1.5B AI investment and reports strong Optum Insight results, boosting growth prospects.

UnitedHealth Group is making artificial intelligence a bigger part of its strategy to strengthen Optum Insight's growth, planning to invest nearly $1.5 billion in AI-related initiatives in 2026, with about one-third earmarked for software products and platforms. The strategy is moving beyond experimentation into commercial products, expanding AI capabilities across autonomous coding, digital prior authorization, real-time payer-provider interfaces, and clinical quality and safety tools. Digital prior authorization is showing early traction, with AI achieving a 96% first-pass approval rate while retaining human review for cases not approved. Value Connect, another AI platform, has helped early customers achieve a 17% reduction in pharmacy costs. Optum Insight generated $5.4 billion in second-quarter 2026 revenues, with operating earnings up 13.6% year over year and margin improving to 25.3%. UnitedHealth trades at a forward price-to-earnings ratio of 18.48, above the industry average of 16.02, and carries a Zacks Rank #1 (Strong Buy).
UnitedHealth Group IncorporatedUnitedHealth announces $1.5B AI investment and reports strong Optum Insight results, boosting growth prospects.
Humana Inc
Centene Corp